MJJ-31678-09397
4 vaccinations
1 coded response
40 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 462 / IN
- Registered
- 2021-06-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JXR-29171-50030
Child or adolescent in my care · Female · 2022-07-07
Timeline
-
2021-06-04
Dose 1 — Moderna
-
2021-06-06
Registered in v-safe
- 2021-06-06
-
2021-06-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-18
- 2021-06-25
-
2021-07-02
Dose 2 — Moderna
- 2021-07-02
- 2021-07-03
- 2021-07-04
- 2021-07-05
- 2021-07-06
- 2021-07-07
- 2021-07-09
- 2021-07-16
- 2021-07-25
- 2021-07-30
- 2021-08-06
- 2021-08-15
- 2021-10-01
-
2021-12-31
Survey response — 6 months, dose 2MedDRA: Pre-eclampsia, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Developed preeclampsia during pregnancy.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-01-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-05
Dose 3 — Moderna
- 2022-01-26
- 2022-02-04
- 2022-02-11
- 2022-02-16
- 2022-04-06
- 2022-07-07
-
2022-09-25
Dose 4 — Moderna
- 2022-09-26
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-04
- 2022-10-10
- 2022-10-18
- 2022-10-23
- 2022-11-01
- 2022-11-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-04 | Moderna | |
| 2 | 2021-07-02 | Moderna | No |
| 3 | 2022-01-05 | Moderna | No |
| 4 | 2022-09-25 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: Developed preeclampsia during pregnancy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release